UBS Group’s Innovator U.S. Equity Accelerated ETF - April XDAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,541
Closed -$162K 11214
2025
Q1
$162K Buy
4,541
+4,423
+3,748% +$159K ﹤0.01% 6693
2024
Q4
$4.19K Buy
118
+18
+18% +$633 ﹤0.01% 8777
2024
Q3
$3.45K Buy
+100
New +$3.35K ﹤0.01% 8265
2024
Q1
Sell
-1,819
Closed -$55.9K 10171
2023
Q4
$55.9K Buy
1,819
+1,583
+671% +$46.4K ﹤0.01% 6476
2023
Q3
$6.67K Buy
+236
New +$6.8K ﹤0.01% 7284
2022
Q2
Sell
-1,311
Closed -$39K 11093
2022
Q1
$39K Sell
1,311
-32
-2% -$912 ﹤0.01% 6745
2021
Q4
$39K Sell
1,343
-191
-12% -$5.41K ﹤0.01% 7157
2021
Q3
$42K Buy
1,534
+1,267
+475% +$35K ﹤0.01% 6485
2021
Q2
$7K Buy
+267
New +$7.08K ﹤0.01% 8360

Other funds holding XDAP

UBS Group's XDAP Position: Q2 2025 in Review

UBS Group sold out of Innovator U.S. Equity Accelerated ETF - April (XDAP) in Q2 2025, closing a stake of 4,541 shares — an estimated $162K sold.

UBS Group first reported a position in XDAP in Q2 2021 and held it in 9 quarters. The position peaked at $162K in Q1 2025. 2 funds tracked by Wall St. Rank hold XDAP as of Q2 2025.

  • UBS Group reported no remaining Innovator U.S. Equity Accelerated ETF - April position as of Q2 2025 after selling out during the quarter.
  • UBS Group sold 4,541 Innovator U.S. Equity Accelerated ETF - April shares in Q2 2025, an estimated $162K.
  • UBS Group first reported a position in Innovator U.S. Equity Accelerated ETF - April in Q2 2021 and held it in 9 quarters.
  • UBS Group's Innovator U.S. Equity Accelerated ETF - April position peaked at $162K in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Innovator U.S. Equity Accelerated ETF - April as of Q2 2025.

Based on UBS Group's 13F filing for Q2 2025, filed 14 Aug 2025.